口服强骨饮联合超声药物透入理疗对绝经后骨质疏松性腰背痛患者临床疗效观察  

QiangGuYin Joint Penetration Ultrasonic Drug in Treatment of Postmenopausal Osteoporosis Clinical Observation of Low Back Pain Patients Quality of Life

作　　者：阮芝芳[1] 李旭云[2] 孙峰[2] 李春雯[2] 史晓林[1] 

机构地区：[1]浙江中医药大学附属第二医院,杭州310005 [2]浙江中医药大学

出　　处：《浙江中医药大学学报》2015年第6期451-453,456,共4页Journal of Zhejiang Chinese Medical University

基　　金：浙江省中医药科学研究基金项目(2014ZB050);国家中医药管理局中医药行业科研专项项目(201307010)~~

摘　　要：[目的]观察口服强骨饮联合超声药物透入理疗绝经后骨质疏松性腰背痛临床疗效。[方法]将64例绝经后有腰背痛的骨质疏松症(osteoporosis,OP)妇女随机分为口服强骨饮联合超声药物透入的治疗组和单纯超声药物透入的对照组,治疗时间为2周,分别于治疗前、治疗1周、2周、3月后问卷调查患者视觉模拟评分(visual analogue scale,VAS)、生活质量评分(medical outcomes study,SF-36),并在3个月后复查两组骨密度(bone mineral density,BMD),对数据进行统计分析。[结果]治疗1周后治疗组VAS值低于对照组,有统计学意义(P<0.05),SF-36值略高于对照组,无统计学意义(P>0.05);治疗2周后两组VAS值均有降低且治疗组VAS值低于对照组,有统计学意义(P<0.05),SF-36值均有升高且治疗组高于对照组,有统计学意义(P<0.05);治疗3月后,经自身对照,两组相较2周时均有VAS值升高、SF-36值降低,但治疗组无显著改变(P>0.05),而对照组有显著改变(P<0.05)。治疗3月后治疗组BMD值与对照组相比,差异无统计学意义(P>0.05)。[结论]口服强骨饮联合超声药物透入理疗在短期内能减轻患者腰背疼痛,改善生活质量,作用持久,是改善绝经后OP妇女腰背痛临床症状的一种有效治疗手段,但短期内不能显著提高BMD。[Objective] To observe the oral QiangGuYin joint penetration ultrasonic drug in treatment of postmenopausa~ osteoporosis clinical curative effect of low back pain. [Methods] 64 women with postmenopansal osteoporosis were randomly divided into oral QiangGuYin joint ultrasonic drugs named treatment group, and pure ultrasonic penetration named control group; Treatment time was 2 cycles, and by questionnaire survey, collect patient pain score VAS and quality of life scores SF-36, respectively before and after treatment 1 week, 2 weeks, 3 months; moreover after three months review of two groups bone mineral density BMD, then make statistical analysis of the results. [Results] After 1 week, treatment group VAS value was lower than the control group, with statistical significance（P〈0.05）; SF-36 value was slightly higher than the control group, with no statistical significance（P〉0.05）; After 2 weeks the treatment groups of VAS values were lower than the control group, with statistical significance（P〈0.05）; SF-36 value increase and the treatment group was higher than the control group, with statistical significance（P〈O.05）; After 3 months, by self-reflection the two groups had VAS values rise and SF-36 value reduced compared with 2 weeks; the treatment group had no significant change（P〈0.05）, while the contrel group had significant changes（P〈 0.05）. After 3 months, compared with the control group, treatment group BMD value had no obvious change, with no statistically significant differenee（P〉 0.05）.[Conclusion] In the short term, the oral QiangGuYin joint drug penetration by ultrasound therapy can reduce low back pain and improve quality of life, even last for some time, but not significantly increase bone mineral density（BMD）, which is an effective treatment to relieve low back pain symptoms for postmenopausal OP women.

关 键 词：强骨饮 超声药物透入 骨质疏松 绝经期 腰背痛 骨密度 生活质量 

分 类 号：R681[医药卫生—骨科学]